ArticleNature biomedical engineering2026
An artificial cilia-based array system for sound frequency decoding and resonance-responsive drug release.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative ensemble learning framework for forecasting controlled drug release based on Raman spectral signatures.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Hair cells in the human ear contain cilia of varying lengths that sense varied acoustic signals. Here, inspired by this, we report an artificial cilia-based sound-decoding device capable of directly recognizing and responding to sound frequencies without relying on electricity and algorithms. We create 3D-printed micrometre-sized (40-200 μm) artificial cilia-based arrays with varying length-to-diameter ratios (30-100) that can sense and decode sound frequency signals (100-6,000 Hz), including piano music and human voices, on the basis of acoustic resonance. The artificial cilia can also vibrate accordingly in water to initiate subsequent tasks such as controlling drug release profiles of two distinct therapeutics (insulin and glucagon) in an acoustic-frequency-responsive manner to treat type 1 diabetic mice. This cochlear cilia-inspired device holds potential for broad applications such as recognizing complicated physiological sounds and performing various tasks in personalized voice interactions.
Indexed as
Identifiers
40993189What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.